Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, Thompson C, Loveless M, Shapiro DE, Elsasser W, et al.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S88-95.

PMID:
8148460
2.

Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.

Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, Fu R, Nelson HD.

Ann Intern Med. 2015 Jun 16;162(12):841-50. doi: 10.7326/M15-0114. Review.

3.

Specific RNA drug therapy of hepatitis viruses.

Carter WA, Suhadolnik RJ, Müller WE, Korba BE, Hubbell HR, Garcia G, Strayer DR.

Ann N Y Acad Sci. 1993 Jun 23;685:758-61. Review. No abstract available.

PMID:
8363282
4.

A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.

Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH, Fitzgerald JT, Goldstein J, O'Neill W.

Drugs Today (Barc). 2002 Aug;38(8):549-61. Review.

PMID:
12582420
5.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
6.

TLR3 agonists as immunotherapeutic agents.

Nicodemus CF, Berek JS.

Immunotherapy. 2010 Mar;2(2):137-40. doi: 10.2217/imt.10.8. Review. No abstract available.

7.

The role of enterovirus in chronic fatigue syndrome.

Chia JK.

J Clin Pathol. 2005 Nov;58(11):1126-32. Review.

8.

Daily physical activity of patients with the chronic fatigue syndrome: a systematic review.

Evering RM, van Weering MG, Groothuis-Oudshoorn KC, Vollenbroek-Hutten MM.

Clin Rehabil. 2011 Feb;25(2):112-33. doi: 10.1177/0269215510380831. Epub 2010 Oct 13. Review.

PMID:
20943713
Items per page

Supplemental Content

Write to the Help Desk